NEW YORK – Immunocore e boletse ka Mantaha hore e tla rekisa likarolo tse 3,733,333 tumellanong ea lichelete ea matsete a poraefete (PIPE) e lebelletsoeng ho bokella $140 milione.
Tlas'a tumellano, Immunocore e tla rekisa setoko sa eona se tloaelehileng le setoko se tloaelehileng se sa vouteng ka $37.50 ka karolo. Batsetedi ba khamphani ba seng ba ntse ba le teng ba kenyang letsoho ho tšehetsa lichelete ba kenyelletsa RTW Investments, Rock Springs Capital le General Atlantic. Tumellano ea PIPE e lebelletsoe ho fela ka la 20 Phupu.
Khamphani e tla sebelisa chelete e fumanoeng ho lefella bakhethoa ba eona ba oncology le mafu a tšoaetsanoang, ho kenyeletsoa le nts'etsopele ea mokhethoa oa eona ea ka sehloohong oa oncology, Kimmtrak (tebentafusp-tebn), ho phekola letlalo le nang le HLA-A*02:01 le melanoma ea uveal. Chelete ena, hammoho le chelete e tsoang ho Kimmtrak, e lebelletsoe ho lefella ts'ebetso ea Immunocore ho fihlela ka 2025.
Selemong sena, Kimmtrak e amohetsoe hore e sebelisoe ho bakuli ba nang le melanoma e sa buuoeng kapa e sa senyeheng ea HLA-A*02:01 US, Europe le UK, har'a linaha tse ling. Immunocore e ntse e tsoela pele ho ithuta moriana ona thutong ea Mokhahlelo oa I/II ho melanoma ea letlalo e nang le HLA-A*02:01.
Immunocore e boetse e ntshetsa pele ba bang ba bane ba nang le oncology, ho kenyeletsoa le meriana e meng e 'meli ea li-receptor tsa T-cell litekong tsa Mokhahlelo oa I/II lihlahleng tse tiileng tse tsoetseng pele. E 'ngoe ea meriana e ntse e etsoa bakeng sa bakuli ba nang le HLA-A*02:01-positive le MAGE-A4-positive, 'me e 'ngoe e shebane le lihlahleng tse nang le HLA-A*02:01 le PRAME-positive. Khamphani e boetse e na le ba bang ba babeli ba sa tsejoeng ba nang le oncology nts'etsopele ea pele ho tleliniki.
Leano la Lekunutu.melao le Maemo.Tokelo ea Mongoli © 2022 GenomeWeb, yuniti ea khoebo ea Crain Communications.litokelo tsohle li sirelelitsoe.